Scorpius Holdings, Inc., a pharmaceutical company with a market capitalization of $1.36 million, has entered into a material definitive agreement through the issuance of a non-convertible promissory ...

Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to ...

NGC 7023, also known as the Iris Nebula, is a reflection nebula in the constellation Cepheus. It's a bright nebula that's visible in the northern sky.

Scorpius Holdings, Inc. has announced a collaboration with KaloCyte to improve the manufacturing efficiency of KaloCyte's lead product, ErythroMer™, a bio-engineered artificial red blood cell ...

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ...

Scorpius Holdings (SCPX) announced that the company’s planned 1-for-20 reverse stock split of its common stock that was announced yesterday, ...

Scorpius Holdings, Inc. DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and ...

ThunderCats: Lost #2 introduces Scorpius, a formidable new foe for the ThunderCats. Bengali, Pumyra, and Lynx-O make a return ...